Markets · Global Equities · US
ABBOTT LABORATORIES ABT
Exchange NYSE. Sector Pharma & biotech. Source: SEC companyfacts. Not a price feed.
- Revenue TTM 48.14B
- EBITDA TTM 8.02B
- Net debt 26.86B
- ND/EBITDA 3.35
- EBITDA/interest 8.05
- ROE 0.09
- Implied band BB